Loading...
Micro-Seminar: Exploring American Addictions: Social Justice in the Representation of the Crack and Opioid Epidemics PART ONE
by
Back to Welcome Week Micro-Seminars 2024
Thu, Aug 22, 2024
3 PM – 4:30 PM PDT (GMT-7)
Private Location (register to display)
5
Registered
Registration
Registration is now closed (this event already took place).
Details
Part 1: Thursday, August 22, 2024 from 3:00 – 4:30 pm (PST)
Part 2: Friday, August 23, 2024 from 10:00 – 11:30 am (PST)
Social Justice is about fair and just relations between individuals and society, ensuring equal access to wealth, opportunities, and privileges. Substance abuse is a social justice issue, deeply rooted in cultural and social identity struggles in modern America. It should not be viewed solely as a criminal or public health issue. Key reasons for this include lack of support for addicted individuals, abuse linked to sex, gender, and age, adverse life experiences, socio-economic inequalities related to the drug trade, and innocent victims harmed by those under the influence. Structural violence refers to social arrangements that harm individuals and populations, becoming embedded in political and economic systems. The U.S. has fought a 40-year war on drugs, particularly crack cocaine and opioids. This war, along with the criminalization of drug use, isolation, and homelessness, has created dangerous environments for people. To provide students with alternative perspectives on addiction:
Day 1: Crack Cocaine, the War Against Drug Users Focus: Socio-political environment of the 1980s, leading to the Crack epidemic and the new War on Drugs, resulting in a rise in incarceration. Activity: Critique media images from the 1980s and 1990s in small groups.
Day 2: OxyContin, the War Against the Drug Manufacturer Focus: Development of "pain" as a diagnosis and the pharmaceutical industry's response, leading to higher potency opioids to meet patient demand. Activity: Critique media images from 2000-2020 in small groups.
Target Audience Anyone interested in the history of addiction, law, justice, and science.
Lead By: Professor Terry Church
Dr. Terry David Church is currently an Assistant Professor in Regulatory and Quality Sciences at the University of Southern California, Mann School of Pharmacy and Pharmaceutical Sciences. He is Assistant Director of Pharmacy Undergraduate Programs. Prof. Church's academic focus is on application of pharmaceutical regulations, patterns of addiction, disaster management, and education and training. His areas of interest and expertise include history and geography of drugs, biorepository regulation and ethics; drug addiction and regulation of controlled substances; regulatory practices for continuity and disaster planning; and policies and ethics for academic research.
Dr. Church received his Doctor of Science and Master of Science in Regulatory Sciences from the University of Southern California. He earned a Master of Arts in Cultural Anthropology from Temple University. His doctoral thesis evaluated regulatory practices for continuity and disaster planning for biobanks in the United States. Dr. Church is a faculty fellow of the USC Center for Excellence in Teaching and Director of the Education and Training Consortium of the Institute for Addiction Sciences. He serves as Co-Director of the STAR science educational program with BRAVO Medical Magnet High School of Los Angeles and USC.
After receiving his Master’s degree from Temple, Dr. Church worked at the University of Pennsylvania’s Office of Human Research as the Operations Director for research. He initially worked to help implement human subjects research protections and monitor all clinical trial activity ongoing and planned. He then took a position at USC Norris Comprehensive Cancer Center as Program Manager. He was responsible for all research, clinical, and community activities for Women’s Cancers, Translational Cancer Research, and Adolescent and Young Adult Cancers. For well over ten years, Dr. Church managed the operation and development of Investigator Initiated Trials.
Agenda
Past Events
Fri, Aug 23, 2024
10:00 AM – 11:30 AM
Private Location (register to display)
10:00 AM – 11:30 AM
Micro-Seminar: Exploring American Addictions: Social Justice in the Representation of the Crack and Opioid Epidemics PART TWO
Micro-Seminars have two parts. Attendance to both parts is required. Registering for the PART ONE session will automatically enroll you in the PART TWO session on Friday.
Part 1: Thursday, August 22, 2024 from 3:00 – 4:30 pm (PST)
Part 2: Friday, August 23, 2024 from 10:00 – 11:30 am (PST)
Social Justice is about fair and just relations between individuals and society, ensuring equal access to wealth, opportunities, and privileges. Substance abuse is a social justice issue, deeply rooted in cultural and social identity struggles in modern America. It should not be viewed solely as a criminal or public health issue. Key reasons for this include lack of support for addicted individuals, abuse linked to sex, gender, and age, adverse life experiences, socio-economic inequalities related to the drug trade, and innocent victims harmed by those under the influence. Structural violence refers to social arrangements that harm individuals and populations, becoming embedded in political and economic systems. The U.S. has fought a 40-year war on drugs, particularly crack cocaine and opioids. This war, along with the criminalization of drug use, isolation, and homelessness, has created dangerous environments for people. To provide students with alternative perspectives on addiction:
Day 1: Crack Cocaine, the War Against Drug Users Focus: Socio-political environment of the 1980s, leading to the Crack epidemic and the new War on Drugs, resulting in a rise in incarceration. Activity: Critique media images from the 1980s and 1990s in small groups.
Day 2: OxyContin, the War Against the Drug Manufacturer Focus: Development of "pain" as a diagnosis and the pharmaceutical industry's response, leading to higher potency opioids to meet patient demand. Activity: Critique media images from 2000-2020 in small groups.
Target Audience Anyone interested in the history of addiction, law, justice, and science.
Lead By: Professor Terry Church
Dr. Terry David Church is currently an Assistant Professor in Regulatory and Quality Sciences at the University of Southern California, Mann School of Pharmacy and Pharmaceutical Sciences. He is Assistant Director of Pharmacy Undergraduate Programs. Prof. Church's academic focus is on application of pharmaceutical regulations, patterns of addiction, disaster management, and education and training. His areas of interest and expertise include history and geography of drugs, biorepository regulation and ethics; drug addiction and regulation of controlled substances; regulatory practices for continuity and disaster planning; and policies and ethics for academic research.
Dr. Church received his Doctor of Science and Master of Science in Regulatory Sciences from the University of Southern California. He earned a Master of Arts in Cultural Anthropology from Temple University. His doctoral thesis evaluated regulatory practices for continuity and disaster planning for biobanks in the United States. Dr. Church is a faculty fellow of the USC Center for Excellence in Teaching and Director of the Education and Training Consortium of the Institute for Addiction Sciences. He serves as Co-Director of the STAR science educational program with BRAVO Medical Magnet High School of Los Angeles and USC.
After receiving his Master’s degree from Temple, Dr. Church worked at the University of Pennsylvania’s Office of Human Research as the Operations Director for research. He initially worked to help implement human subjects research protections and monitor all clinical trial activity ongoing and planned. He then took a position at USC Norris Comprehensive Cancer Center as Program Manager. He was responsible for all research, clinical, and community activities for Women’s Cancers, Translational Cancer Research, and Adolescent and Young Adult Cancers. For well over ten years, Dr. Church managed the operation and development of Investigator Initiated Trials.